Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Advanced glycation end products cause collagen II reduction by activating Janus kinase/signal transducer and activator of transcription 3 pathway in porcine chondrocytes.

Huang CY, Lai KY, Hung LF, Wu WL, Liu FC, Ho LJ.

Rheumatology (Oxford). 2011 Aug;50(8):1379-89. doi: 10.1093/rheumatology/ker134. Epub 2011 Apr 10.

PMID:
21482542
2.

A benzamide-linked small molecule HS-Cf inhibits TNF-α-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics.

Liu FC, Huang HS, Huang CY, Yang R, Chang DM, Lai JH, Ho LJ.

J Clin Immunol. 2011 Dec;31(6):1131-42. doi: 10.1007/s10875-011-9576-9. Epub 2011 Aug 20.

PMID:
21858617
3.

Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.

El Mabrouk M, Sylvester J, Zafarullah M.

Biochim Biophys Acta. 2007 Mar;1773(3):309-20. Epub 2006 Dec 15.

4.

Effects and relationship of ERK1 and ERK2 in interleukin-1β-induced alterations in MMP3, MMP13, type II collagen and aggrecan expression in human chondrocytes.

Wang X, Li F, Fan C, Wang C, Ruan H.

Int J Mol Med. 2011 Apr;27(4):583-9. doi: 10.3892/ijmm.2011.611. Epub 2011 Feb 3.

PMID:
21305249
5.

Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes.

Liu FC, Hung LF, Wu WL, Chang DM, Huang CY, Lai JH, Ho LJ.

Arthritis Res Ther. 2010;12(5):R167. doi: 10.1186/ar3127. Epub 2010 Sep 8.

7.

Activation of cartilage matrix metalloproteinases by activated protein C.

Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB.

Arthritis Rheum. 2009 Mar;60(3):780-91. doi: 10.1002/art.24303.

8.

Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.

Yang Q, Chen C, Wu S, Zhang Y, Mao X, Wang W.

Eur J Pharmacol. 2010 Dec 15;649(1-3):108-14. doi: 10.1016/j.ejphar.2010.09.025. Epub 2010 Sep 20.

PMID:
20863825
9.

Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.

Yasuda T, Tchetina E, Ohsawa K, Roughley PJ, Wu W, Mousa A, Ionescu M, Pidoux I, Poole AR.

Matrix Biol. 2006 Sep;25(7):419-29. Epub 2006 Jun 30.

PMID:
16919430
10.

COX-2 and iNOS are critical in advanced glycation end product-activated chondrocytes in vitro.

Huang CY, Hung LF, Liang CC, Ho LJ.

Eur J Clin Invest. 2009 May;39(5):417-28. doi: 10.1111/j.1365-2362.2009.02106.x.

PMID:
19371268
11.

Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice.

Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, Goumans MJ, van den Berg WB, van der Kraan PM.

J Immunol. 2009 Jun 15;182(12):7937-45. doi: 10.4049/jimmunol.0803991. Erratum in: J Immunol. 2010 Aug 15;185(4):2629.

12.

Matrix metalloproteinase-13 expression in IL-1β-treated chondrocytes by activation of the p38 MAPK/c-Fos/AP-1 and JAK/STAT pathways.

Lim H, Kim HP.

Arch Pharm Res. 2011 Jan;34(1):109-17. doi: 10.1007/s12272-011-0113-4. Epub 2011 Apr 6.

PMID:
21468922
13.

[Protective effect of LR-90 on articular cartilage in rabbit model of osteoarthritis].

Huang K, Zhang J, Wan J, Lu J, Gao Y.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 Mar;45(2):187-94. Chinese.

PMID:
27273993
14.

Rho/ROCK and MEK/ERK activation by transforming growth factor-alpha induces articular cartilage degradation.

Appleton CT, Usmani SE, Mort JS, Beier F.

Lab Invest. 2010 Jan;90(1):20-30. doi: 10.1038/labinvest.2009.111. Epub 2009 Oct 12.

15.

Identification of soluble 14-3-3∊ as a novel subchondral bone mediator involved in cartilage degradation in osteoarthritis.

Priam S, Bougault C, Houard X, Gosset M, Salvat C, Berenbaum F, Jacques C.

Arthritis Rheum. 2013 Jul;65(7):1831-42. doi: 10.1002/art.37951.

16.

Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes.

Rosa SC, Rufino AT, Judas FM, Tenreiro CM, Lopes MC, Mendes AF.

J Cell Biochem. 2011 Oct;112(10):2813-24. doi: 10.1002/jcb.23196.

PMID:
21608018
17.

Glucan HBP-A increase type II collagen expression of chondrocytes in vitro and tissue engineered cartilage in vivo.

Cao YL, Liu T, Pang J, Gao NY, Zhan HS, Shi YY, Wang X, Wang SC.

Chin J Integr Med. 2015 Mar;21(3):196-203. doi: 10.1007/s11655-013-1511-x. Epub 2013 Jul 16.

PMID:
23860800
18.

Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.

Jayasuriya CT, Goldring MB, Terek R, Chen Q.

Arthritis Res Ther. 2012 Sep 11;14(5):R197. doi: 10.1186/ar4033.

19.

Down-regulated HS6ST2 in osteoarthritis and Kashin-Beck disease inhibits cell viability and influences expression of the genes relevant to aggrecan metabolism of human chondrocytes.

Wang W, Zhong B, Sun J, Cao J, Tian J, Zhong N, Zhao W, Tian L, Xu P, Guo D, Ju X, Ma W, Li M, Hou W, Lu S.

Rheumatology (Oxford). 2011 Dec;50(12):2176-86. doi: 10.1093/rheumatology/ker230. Epub 2011 Oct 4.

PMID:
21972422
20.

Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes.

Henrotin YE, Deberg MA, Crielaard JM, Piccardi N, Msika P, Sanchez C.

J Rheumatol. 2006 Aug;33(8):1668-78.

PMID:
16832844

Supplemental Content

Support Center